Cargando…
Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemia.
Sublines of a human myeloid leukaemia cell line, KBM-3, with increasing degrees of resistance to the antileukaemic agent 4'-(9-acridinlylamino) methanesulphon-m-anisidide (m-AMSA) were evaluated for their response to this drug using a clonogenic assay to measure cell survival and alkaline eluti...
Autores principales: | Skinner, W. L., Murray, D., Kohli, V., Beran, M., McCredie, K. B., Freireich, E. J., Andersson, B. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971335/ https://www.ncbi.nlm.nih.gov/pubmed/2297490 |
Ejemplares similares
-
Enhanced killing of mammalian cells by radiation combined with m-AMSA.
por: Roberts, P. B., et al.
Publicado: (1980) -
The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate.
por: Tudor, R. J., et al.
Publicado: (1983) -
Clonal variation in the sensitivity of B16 melanoma to m-AMSA.
por: Stephens, T. C., et al.
Publicado: (1982) -
A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.
por: West, C., et al.
Publicado: (1981) -
Human myeloid leukaemic cell interactions in vitro with normal myeloid colonies.
por: Spitzer, G., et al.
Publicado: (1981)